Livtencity
NDC 64764-800, MARIBAVIR, tablet, coated, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 64764-800
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215596
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64764-800 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MARIBAVIR200 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Cytomegalovirus pUL97 Kinase Inhibitor [EPC]; Cytomegalovirus pUL97 Kinase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64764-800-28 | 64764080028 | 1 BOTTLE in 1 CARTON (64764-800-28) / 28 TABLET, COATED in 1 BOTTLE |
| 64764-800-56 | 64764080056 | 1 BOTTLE in 1 CARTON (64764-800-56) / 56 TABLET, COATED in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c94fc2c5-e840-4f18-b7d8-d5eacb26d3a0
Use it
Look up 64764-800 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64764-800 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64764-800. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.